Korean Drug Co Stock Shares Owned By Insiders
014570 Stock | KRW 4,155 115.00 2.69% |
Korean Drug Co fundamentals help investors to digest information that contributes to Korean Drug's financial success or failures. It also enables traders to predict the movement of Korean Stock. The fundamental analysis module provides a way to measure Korean Drug's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Korean Drug stock.
Korean |
Korean Drug Co Company Shares Owned By Insiders Analysis
Korean Drug's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Korean Drug Shares Owned By Insiders | 50.19 % |
Most of Korean Drug's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Korean Drug Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition |
Based on the latest financial disclosure, 50% of Korean Drug Co are shares owned by insiders. This is 230.63% higher than that of the Healthcare sector and significantly higher than that of the Pharmaceuticals industry. The shares owned by insiders for all Republic of Korea stocks is notably lower than that of the firm.
Korean Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Korean Drug's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Korean Drug could also be used in its relative valuation, which is a method of valuing Korean Drug by comparing valuation metrics of similar companies.Korean Drug is currently under evaluation in shares owned by insiders category among its peers.
Korean Fundamentals
Return On Equity | 15.3 | |||
Return On Asset | 0.0702 | |||
Profit Margin | 0.11 % | |||
Operating Margin | 0.14 % | |||
Current Valuation | 94.01 B | |||
Shares Outstanding | 11 M | |||
Shares Owned By Insiders | 50.19 % | |||
Shares Owned By Institutions | 0.28 % | |||
Price To Earning | 55.67 X | |||
Price To Sales | 1.11 X | |||
Revenue | 74.47 B | |||
Gross Profit | 28.69 B | |||
EBITDA | 11.14 B | |||
Net Income | 9.04 B | |||
Cash And Equivalents | 4.68 B | |||
Cash Per Share | 980.50 X | |||
Total Debt | 15 M | |||
Debt To Equity | 0.10 % | |||
Current Ratio | 6.69 X | |||
Cash Flow From Operations | 8.81 B | |||
Number Of Employees | 14 | |||
Beta | 0.25 | |||
Market Capitalization | 84.81 B | |||
Total Asset | 88.61 B | |||
Retained Earnings | 40.74 B | |||
Working Capital | 33.63 B | |||
Current Asset | 40.97 B | |||
Current Liabilities | 7.34 B | |||
Annual Yield | 0.01 % | |||
Net Asset | 88.61 B |
About Korean Drug Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Korean Drug Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Korean Drug using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Korean Drug Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Korean Drug
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Korean Drug position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Korean Drug will appreciate offsetting losses from the drop in the long position's value.Moving against Korean Stock
0.53 | 032830 | Samsung Life | PairCorr |
0.47 | 316140 | Woori Financial Group | PairCorr |
0.37 | 105560 | KB Financial Group | PairCorr |
0.34 | 216080 | JETEMA | PairCorr |
0.31 | 065660 | AnterogenCoLtd | PairCorr |
The ability to find closely correlated positions to Korean Drug could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Korean Drug when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Korean Drug - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Korean Drug Co to buy it.
The correlation of Korean Drug is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Korean Drug moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Korean Drug moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Korean Drug can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Korean Stock
Korean Drug financial ratios help investors to determine whether Korean Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Korean with respect to the benefits of owning Korean Drug security.